# Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder

> **NCT02527564** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 61 (actual)

## Conditions studied

- Insomnia
- Bipolar Disorder

## Interventions

- **DRUG:** Suvorexant
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02527564
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-03-01
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2022-10-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02527564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02527564, "Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02527564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*